High-throughput methods for characterizing the immune repertoire
Author(s)
Laserson, Uri
DownloadFull printable version (21.52Mb)
Other Contributors
Harvard--MIT Program in Health Sciences and Technology.
Advisor
George M Church.
Terms of use
Metadata
Show full item recordAbstract
The adaptive immune system is one of the primary mediators in almost every major human disease, including infections, cancer, autoimmunity, and inflammation-based disorders. It fundamentally functions as a molecular classifier, and stores a memory of its previous exposures. However, until recently, methods to unlock this information or to exploit its power in the form of new therapeutic antibodies or affinity reagents have been limited by the use of traditional, low-throughput technologies. In this thesis, we leverage recent advances in high-throughput DNA sequencing technology to develop new methods to characterize and probe the immune repertoire in unprecedented detail. We use this technology to 1) characterize the rapid dynamics of the immune repertoire in response to influenza vaccination, 2) characterize elite neutralizing antibodies to HIV, to better understand the constraints for designing an HIV vaccine, and 3) develop new methodologies for discovering auto-antigens, and assaying large libraries of protein antigens in general. We hope that these projects will serve as stepping-stones towards filling the gap left by low-throughput methods in the development of antibody technologies.
Description
Thesis (Ph. D. in Biomedical Engineering and Computational Biology)--Harvard-MIT Program in Health Sciences and Technology, February 2013. "September 2012." Cataloged from PDF version of thesis. Includes bibliographical references (p. 147-160).
Date issued
2013Department
Harvard University--MIT Division of Health Sciences and TechnologyPublisher
Massachusetts Institute of Technology
Keywords
Harvard--MIT Program in Health Sciences and Technology.